Mithra Pharmaceuticals SA (MITPF)
6.75
0.00 (0.00%)
USD |
OTCM |
May 09, 16:00
Mithra Pharmaceuticals PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| November 19, 2020 | 19.82 |
| November 18, 2020 | 19.82 |
| November 17, 2020 | 19.82 |
| November 16, 2020 | 19.82 |
| November 13, 2020 | 19.82 |
| November 12, 2020 | 19.82 |
| November 11, 2020 | 19.82 |
| November 10, 2020 | 19.82 |
| Date | Value |
|---|---|
| November 09, 2020 | 19.82 |
| November 06, 2020 | 19.82 |
| November 05, 2020 | 19.82 |
| November 04, 2020 | 19.82 |
| November 03, 2020 | 19.82 |
| November 02, 2020 | 19.82 |
| October 30, 2020 | 19.82 |
| October 29, 2020 | 19.82 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
19.82
Minimum
Oct 29 2020
19.82
Maximum
Oct 29 2020
19.82
Average
19.82
Median
Oct 29 2020
PE Ratio Benchmarks
| Galapagos NV | 6.265 |
| UCB SA | 69.08 |
| Nyxoah SA | -- |
| Celyad Oncology SA | -- |
| MDxHealth SA | -- |
PE Ratio Related Metrics
| Price | 6.75 |
| Market Cap | 451.63M |